show help

Snoeck R

Author page

This page provides a summary of the entries in Polbase associated with this author.

The publication history graph presents the number of publications in Polbase by this author over time.

The polymerase chart indicates which polymerases this author has published on.

Polbase automatically discovers many polymerase papers as they are published. Some relevant papers are not included because the algorithm is designed to reduce background. Please contribute to polbase by adding your missing DNA polymerase papers.

Help icons:

The show help symbol in the upper-right corner of the page links to this help text. The question mark icon is used everywhere to indicate that help is available.

Missing references?


Title Authors Year Journal
[Current acquisitions in antiviral drugs (anti-HIV)]. Snoeck R Journal de pharmacie de Belgique
A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity. Snoeck R 2013 PLoS pathogens
N(1),N(3)-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase. Snoeck R 2013 Bioorganic & medicinal chemistry
In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs. Snoeck R 2012 Journal of virology
Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus. Snoeck R 2012 Journal of virology
Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates. Snoeck R 2011 Journal of medicinal chemistry
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. Snoeck R 2011 Cell host & microbe
GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions. Snoeck R 2009 Antimicrobial agents and chemotherapy
Drug targets in cytomegalovirus infection. Snoeck R 2009 Infectious disorders drug targets
Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs. Snoeck R 2008 J Virol
4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action. Snoeck R 2008 Journal of medicinal chemistry
DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions. Snoeck R 2007 Antivir Ther
Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships. Snoeck R 2007 Nucleosides, nucleotides & nucleic acids
Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice. Snoeck R 2006 Journal of virology
Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses. Snoeck R 2006 Antiviral research
Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides. Snoeck R 2005 Antimicrobial agents and chemotherapy
Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Snoeck R 2005 Antimicrobial agents and chemotherapy
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? Snoeck R 2004 Antiviral research
Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV. Snoeck R 2003 Antiviral chemistry & chemotherapy
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. Snoeck R 2002 Antiviral research
Evaluating phenotype and genotype of drug-resistant strains in herpesviruses. Snoeck R 2001 Molecular biotechnology
Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. Snoeck R 2000 The Journal of general virology
Anti-(herpes simplex virus) activity of 4'-thio-2'-deoxyuridines: a biochemical investigation for viral and cellular target enzymes. Snoeck R 2000 The Biochemical journal
Novel agents for the therapy of varicella-zoster virus infections. Snoeck R 2000 Expert opinion on investigational drugs
Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Snoeck R 1999 Drugs
[Highly specific inhibitors of human immunodeficiency virus type I that are particularly targeted at the reverse transcriptase]. Snoeck R 1993 Pathologie-biologie
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Snoeck R 1992 Molecular pharmacology
9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo. Snoeck R 1991 Proceedings of the National Academy of Sciences of the United States of America

Using Polbase tables:


Tables may be sorted by clicking on any of the column titles. A second click reverses the sort order. <Ctrl> + click on the column titles to sort by more than one column (e.g. family then name).


It is also possible to filter the table by typing into the search box above the table. This will instantly hide lines from the table that do not contain your search text.